EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 79 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,500 | -32.8% | 10,384 | -9.1% | 0.04% | -30.8% |
| Q2 2023 | $88,521 | +6.1% | 11,422 | -8.7% | 0.05% | +13.0% |
| Q1 2023 | $83,422 | -46.1% | 12,507 | -27.8% | 0.05% | -43.2% |
| Q4 2022 | $154,787 | -10.0% | 17,314 | -0.9% | 0.08% | +17.4% |
| Q3 2022 | $172,000 | +24.6% | 17,469 | +0.7% | 0.07% | +35.3% |
| Q2 2022 | $138,000 | +74.7% | 17,341 | +113.3% | 0.05% | +45.7% |
| Q1 2022 | $79,000 | -39.7% | 8,129 | -5.5% | 0.04% | -28.6% |
| Q4 2021 | $131,000 | – | 8,604 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
| Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
| Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
| Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
| Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
| DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
| EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
| Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
| Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |